Deep 6 AI news


Volume 2, Issue 1



Cedars-Sinai taps AI to pinpoint patients for clinical trials

Cedars Sinai taps AI to pinpoint patients for clinical trials

Every provider knows that finding enough patients to take part in clinical trials is tough and involves a painstaking search. Bobbie Rimel, MD, a gynecologic oncologist and associate director for gynecological clinical trials at Cedars-Sinai Medical Center, found a way to search through records for patient matching for much better recruitment and ROI -- working with Deep 6 AI. 

“[Deep 6 AI's software] knows ‘I think this is what you mean here.’ That’s incredibly powerful," Rimel said. "Say it nine different ways, in a different font; it’s close enough.”

The correct inclusion of all patients with the same type of cancer also ensures that those who fit the criteria are given the opportunity to take part in a clinical trial -- and that may the biggest reason of all to apply AI in this case. 

“This is a pretty powerful opportunity for hospitals,” she said.

Read the Healthcare IT News article.



Finding the ROI of AI
at HIMSS18

Finding the ROI of AI session at HIMSS18

Deep 6 AI CEO Wout Brusselaers and Cedars-Sinai Medical Center oncologist Bobbie J. Rimel, MD, will co-present “Finding the ROI of AI” at HIMSS18 on March 8, 2018. This educational session will explore the role of artificial intelligence in enabling health systems to perform more clinical trials, boost revenues, attract and retain talent, and provide patients with access to cutting-edge treatments. Read about our ROI session and HIMSS' peer-review selection process.



Texas Medical Center selects
Deep 6 AI for accelerator

Texas Medical Center selects Deep 6 AI for accelerator

Deep 6 AI is one of 23 digital health startups participating in the Texas Medical Center Accelerator (TMCx). TMC is the world's largest medical center with 58 member institutions and a central research institute that provides a campus-wide R&D network, a central IRB for conducting multi-site trials, and 10 million annual patient encounters. The TMCx program lowers the barriers of access to hospital stakeholders and key opinion leaders across TMC. Read about Deep 6 AI and TMCx.



Taking Digital Health Summit
@ CES 2018 by storm


CEO Wout Brusselaers presented at the Digital Health Summit @ CES 2018 as part of the "Trailblazers From the DigitalFrontier" session on the latest advances in AI, VR, biometrics, diagnostics and genomics. Watch the video.


Read what the Twitterverse had to say 




ICYMI: Our 2017 in review


While 2018 is off to a strong start, Deep 6 AI had a stellar 2017. We won our category at SXSW; met Joe Biden and discussed our role in the fight to end cancer; were named one of the top 100 most disruptive companies in the world; saw amazing interest and traction with major provider sites, CROs, and sponsors; saw real results from clinicians using our software; and much, much more! Check out these 2017 highlights.




Reading list 

Industry happenings


Health IT Analytics

HIMSS18 is all about artificial intelligence in healthcare
"Cedars-Sinai Medical Center will also help attendees understand the potential ROI of artificial intelligence, but will focus on its expanding role in clinical trials and research. Bobbie J. Rimel, a gynecologic oncologist and Associate Director for Gynecological Clinical Trials, will be joined by Deep 6 AI CEO Wout Brusselaers to explain how AI tools are improving patient matching and speeding up the process of filling clinical trials.”


Is it time to promote clinical trials as important patient care regimen?
"Studies have found that, in some diabetic trials, there was a reduction in cost of care for people somewhere in the magnitude between 60% and 70%....We have [also] seen a significant improvement in outcomes for patients.”


Experts weigh in: How will health technology advance in 2018?
"Clinical trials is another area in which AI and machine learning hold a great deal of promise. Companies such as Verily, Deep 6 AI, and Medable are applying AI and machine learning to reinvent clinical trial recruitment and fill trials faster."


ROI continues to decline for top pharma firms: Deloitte
"To boost R&D productivity, the industry needs to embrace technologies such as artificial intelligence, real-world evidence, social media, wearable devices and robotics."


AI predictions for 2018: Breakthroughs in health care, not in cars
"Health care is an industry where we can expect AI to take off, with immediate and measurable impact."

GE | The Pulse

We asked top clinicians what AI will do for healthcare in 2018. Here’s what they said
"...hospitals are evolving from asking 'why should I adopt [AI]?' to 'when?'”

Health IT Analytics

ONC: Artificial intelligence has potential to reshape healthcare
“The new report…concludes that the broad advances in AI are significant and real." 


Healthcare is hemorrhaging data. AI is here to help
"...big data-crunching algorithms could save medicine and pharma up to $100 billion a year, as a result of AI-assisted efficiencies in clinical trials, research, and decision-making in the doctor’s office."




We're speaking!

Upcoming events


UCLA Anderson Healthcare Conference 2018

UCLA Anderson Healthcare Conference
Feb 24  Los Angeles, CA

HIMSS 2018

Mar 5 • Las Vegas, NV


SXSW: Connect to End Cancer

SXSW: Connect to End Cancer
Mar 10 • Austin, TX
Bridging Clinical Research & Clinical Health Care

Bridging Clinical Research & Clinical Health Care
Apr 4  National Harbor, MD


DIA 2018

DIA 2018
Jun 25  Boston, MA



You received this email because you are subscribed to Newsletter from Deep 6 AI.

Unsubscribe from all future emails | Update your email preferences


Cedars-Sinai Accelerator powered by Techstars


SXSW Accelerator Pitch 2017 - Enterprise and Smart Data Category Winner